Search by topic:


Brain cancer vaccine

post-image

The Guadian's Denis Campbell reports that trial results suggest people with newly diagnosed glioblastoma could potentially be given extra years of life. 

A senior NHS doctor, Prof Keyoumars Ashkanwho, was one of the trial’s chief investigators said the evidence showed DCVax had resulted in “astonishing” enhanced survival for patients.

Overall 13% of people who received it lived for at least five years after diagnosis.  The vaccine is a form of immunotherapy, in which the body’s immune system is programmed to track down and attack the tumour. It is the first developed to tackle brain tumours. 

https://www.theguardian.com/science/2022/nov/17/vaccine-shown-to-prolong-life-patients-aggressive-brain-cancer-trial-glioblastoma




What do you think?


You must be logged in to post a comment.
Comments

Related Posts

Healthcare

post-image

Future Therapist Chatbot
22 January 2023 by Prof.(Dr.) Sa... 0 Comments

Healthcare

post-image

A wearable smart badge that can translate your speech
21 January 2023 by IdeaSpies 0 Comments

Healthcare

post-image

Social Media Platform that Connects People with Similar Health Conditions
18 January 2023 by Jeremy Ungar 0 Comments